1. MicroRNA Signature in Renal Cell Carcinoma
   Soudeh Ghafouri-Fard et al, 2020, Front. Oncol. CrossRef
2. Liver Kinase B1 (LKB1) Regulates Proliferation and Apoptosis of Non-Small Cell Lung Cancer A549 Cells via Targeting ERK Signaling Pathway
   Yirong Wang et al, 2021, CMAR CrossRef
3. MicroRNA-133b Inhibits nTumor Cell Proliferation, Migration and Invasion by Targeting SUMO1 in Endometrial Carcinoma
   Lingyun Liao et al, 2021, Technol Cancer Res Treat CrossRef
4. Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a
   Yang Liu et al, 2022, Front. Oncol. CrossRef
5. Applications of noncoding RNAs in renal cancer patients
   Eman A. Toraih et al, 2022 CrossRef
6. Circ_0039569 Competes with MARCKS for miR-133b Binding Sites to Promote the Progression of Renal Cell Carcinoma
   Peng Zhao et al, 2022, Nephron CrossRef
7. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer
   Jonathan Xu et al, 2022 CrossRef
8. ADAM metallopeptidase domain 10 knockdown enables podocytes to resist high glucose stimulation by inhibiting pyroptosis via MAPK pathway
   Chunjie Sui et al, 2023, Exp Ther Med CrossRef
9. Exosomes in renal cell carcinoma: challenges and opportunities
   Mahan Mohammadi et al, 2024, Mol Biol Rep CrossRef
10. Matrix metalloproteinases as the critical regulators of cisplatin response and tumor cell invasion
    Iman Akhlaghipour et al, 2024, European Journal of Pharmacology CrossRef
11. Flavokawain A suppresses the malignant progression of neuroblastoma in vitro depending on inactivation of ERK/VEGF/MMPs signaling pathway
    Mengyao Dong et al, 2024, Discov Onc CrossRef